Saira Ramasastry - Jul 11, 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Howard Horn, Attorney-in-Fact
Stock symbol
VIR
Transactions as of
Jul 11, 2022
Transactions value $
-$86,200
Form type
4
Date filed
7/13/2022, 04:05 PM
Previous filing
Jun 27, 2022
Next filing
Dec 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Award $63.8K +5K +61.79% $12.76 13.1K Jul 11, 2022 Direct
transaction VIR Common Stock Sale -$150K -5K -38.19% $30.00 8.09K Jul 11, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Options Exercise $0 -5K -10.47% $0.00 42.8K Jul 11, 2022 Common Stock 5K $12.76 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 28, 2022.
F2 1/3 of the shares subject to the stock option vested and became exercisable on September 4, 2020, and the remaining shares vest in 24 equal monthly installments thereafter.